Código QR (código de barras bidimensional)

Safety and Tolerability of Combining CGRP Monoclonal Antibodies with Gepants in Patients with Migraine: A Retrospective Study

Abstract Introduction The introduction of clacitonin gene-related peptide (CGRP) monoclonal antibodies (mAbs) has revolutionized the treatment of migraines. In clinical practice gepants might be considered as a valid option to treat acute attacks in patients with migraine who are treated with mAbs....

ver descrição completa

Na minha lista:
Principais autores: Taoufik Alsaadi, Reem Suliman, Vanessa Santos, Ibrahim Al Qaisi, Princess Carmina, Batool Aldaher, Shadi Haddad, Yazan Bader
Formato: Artigo
Idioma:Inglês
Publicado em: Adis, Springer Healthcare 2024-02-01
coleção:Neurology and Therapy
Assuntos:
CGRP mAbs
Erenumab
Eptinezumab
Gepants
Migraine
Safety
Acesso em linha:https://doi.org/10.1007/s40120-024-00586-w
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados